Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Industries
Industries
Health
Products 1 to 10 of 63
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
ActoBiotics: AG017 (Celiac Disease)
by
Actobio Therapeutics
Biotech components:
Bacteria
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:12 (4 years ago)
Date last modified:
2019/09/16 16:28 (4 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Health
+
Medical
Market status:
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Personal Care (Ingested)
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Antibiotic - EV-035
by
Emergent Biosolutions, Inc.
Biotech components:
Bacteria
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Switzerland
Intended consumer:
Government
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/08/30 11:49 (5 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Finished Product
Artemisinic Acid
by
Amyris
Biotech components:
Probiotic
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Africa
+
France
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/08/30 11:49 (5 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Input
Attenuated Virus Cultures for Vaccine Production
by
J. Craig Venter
Biotech components:
Virus
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/08/30 11:49 (5 years ago)
Known funding amount:
27,400,000 USD
Funding types:
Research Institution
Industry:
Health
Market status:
Under Development
Organization type(s):
University
+
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
AZT-01
by
Azitra
Biotech components:
Bacteria
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:14 (4 years ago)
Date last modified:
2019/09/12 15:14 (4 years ago)
Known funding amount:
N/A
Funding types:
Government
+
Private Funding
Industry:
Health
+
Medical
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
N/A
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
AZT-02
by
Azitra
Biotech components:
Bacteria
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:14 (4 years ago)
Date last modified:
2019/09/12 15:14 (4 years ago)
Known funding amount:
N/A
Funding types:
Government
+
Private Funding
Industry:
Health
+
Medical
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
N/A
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
AZT-04
by
Azitra
Biotech components:
Bacteria
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:15 (4 years ago)
Date last modified:
2019/09/12 15:15 (4 years ago)
Known funding amount:
N/A
Funding types:
Government
+
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
N/A
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
AZT-05
by
Azitra
Biotech components:
Bacteria
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:14 (4 years ago)
Date last modified:
2019/09/12 15:14 (4 years ago)
Known funding amount:
N/A
Funding types:
Government
+
Private Funding
Industry:
Health
+
Medical
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
N/A
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Bacteriophage Treatment
by
MIT
Biotech components:
Virus
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/08/30 11:49 (5 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
University
+
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
BIO-SA Based Personal Care Products
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2C
Country of production:
Canada
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/11/08 14:29 (5 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Personal Care
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Finished Product
1
2
3
4
5
6
7
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
